"A center of excellence at the University of Arkansas for Medical Sciences, the Winthrop P. Rockefeller Cancer Institute is Arkansas’ only comprehensive cancer treatment and research facility."

During the past decade, Arkansas Cancer Research Center at University of Arkansas for Medical Sciences conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 48 clinical trials were completed, i.e. on average, 960% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences" #1 sponsor was "SWOG Cancer Research Network" with 51 trials, followed by "Children's Oncology Group" with 46 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored and "National Cancer Institute (NCI)" with 8 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Children's Oncology Group" with 5 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences" are "Breast Cancer" (21 trials), "Leukemia" (17 trials), "Sarcoma" (15 trials), "Lymphoma" (13 trials) and "Lung Cancer" (11 trials). Many other conditions were trialed in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences" in a lesser frequency.

Most popular intervention types in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences" are "Drug" (122 trials), "Biological" (48 trials), "Procedure" (40 trials), "Radiation" (33 trials) and "Other" (19 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (31 trials), "filgrastim" (24 trials), "radiation therapy" (24 trials), "etoposide" (23 trials) and "vincristine sulfate" (17 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences" are 122 trials for "All" genders, 21 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Arkansas Cancer Research Center at University of Arkansas for Medical Sciences". undefined are not yet recruiting, 1 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 121 completed trials in Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, 7 "Phase 1" clinical trials were conducted, 72 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".